HOME >> MEDICINE >> NEWS
The worldwide prevalence of glaucoma is increasing

Early diagnosis of glaucoma is essential to prevent irreversible visual impairment, according to a Seminar in this week's issue of THE LANCET.

Glaucoma is a group of disorders that progressively damage the optic nerve in the eye and without treatment can cause visual disability and eventual blindness. Glaucoma affects more than 66 million people worldwide and is the second leading cause of blindness. In the USA, health costs from glaucoma-related blindness have been estimated to be in excess of US $1.5billion a year, and the magnitude of the problem will increase as the population ages.

Robert N. Weinreb from the University of California San Diego, USA, and Peng Tee Khaw from the Moorfields Eye Hospital and Institute of Ophthalmology, London, UK, address primary open-angle glaucoma, an age-related and insidious form of the disease.

Loss of vision from glaucoma can be limited by currently available therapies if the disease is identified in its early stages. However, most cases are not discovered until vision has already been permanently affected, because clinical signs of early glaucoma may be subtle, even to an eye specialist. Although the risk of developing glaucoma increases substantially with the level of pressure in the eye and increasing age, the authors note that measurement of this pressure alone is not an effective method for diagnosis. Assessments of the optic disc, retinal nerve fibre layer, and visual function provide complementary information and new imaging and psychophysical tests can improve both detection and monitoring of the progression of the disease.

Weinreb and Khaw conclude that examination of the optic nerve is an essential component of the adult eye assessment and is the most effective way to identify individuals with glaucoma. The authors stress "the importance of early diagnosis to initiate pressure-lowering treatment and early detection of progression to advance this treatment."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
20-May-2004


Page: 1

Related medicine news :

1. New estimates for the causes of child deaths worldwide
2. Study provides new estimates of the causes of child mortality worldwide
3. Urgent action required to prevent 500k deaths/yr worldwide from pregnancy-related causes
4. Stevens Cattabiani helps link doctors, hospitals worldwide
5. Use of rubella vaccine is growing worldwide, but more work remains
6. Caloric sweetener use grows worldwide; soft drinks are chief culprit, study shows
7. Nearly 5 million deaths worldwide caused by smoking
8. Italy now faces worldwide storm of protest over fertility proposals
9. CDC MMWR: New data on TB epidemics worldwide
10. Brain image database benefits research and education worldwide
11. Is a one child policy worldwide the solution to human population growth?

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The worldwide prevalence glaucoma increasing

(Date:4/23/2014)... Cancer Center researchers say clinical trials for a ... (AML) are very promising. Patients treated with CPX-351, ... daunorubicin, are showing better responses than patients treated ... , "Acute myeloid leukemia is an aggressive blood ... especially in older patients," explained Jeffrey Lancet, M.D., ...
(Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
(Date:4/23/2014)... that targets an important brain receptor has a dramatic ... relapse behavior, a University at Buffalo animal study has ... may be a novel lead compound for treating cocaine ... research was published as an online preview article in ... the compound, RO5263397, severely blunted a broad range of ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
Cached News: